Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Myocardial Revascularization in Two Patients Associated with Antiphospholipid Syndrome: Different Pathogenic Patterns and Angiographic Results

  • Park, Samina (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Hwang, Ho-Young (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Kang, Hyun-Jae (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Kim, Ki-Bong (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
  • Received : 2011.06.22
  • Accepted : 2011.08.24
  • Published : 2011.12.05
Download PDF
⟨ Previous Next ⟩

Abstract

We report on two women who underwent myocardial revascularization associated with antiphospholipid syndrome (APS) with different pathogenic patterns. The first woman presented with acute myocardial infarction, and preoperative angiograms demonstrated rapidly progressing coronary lesions, presumptive unstable plaque, and dissection. Operative findings, however, showed fresh thrombi in the coronary arteries, and she was diagnosed postoperatively as having APS. Her one-year angiogram demonstrated improved coronary lesions and a competitive flow pattern in the grafts. The second woman presented with unstable angina and had been treated for systemic lupus erythematosus and secondary APS for more than 14 years. She underwent myocardial revascularization due to accelerated coronary atherosclerosis. Her one-year angiogram demonstrated patent grafts.

Keywords

References

  1. Soltész P, Szekanecz Z, Kiss E, Shoenfeld Y. Cardiac manifestations in antiphospholipid syndrome. Autoimmun Rev 2007;6:379-86. https://doi.org/10.1016/j.autrev.2007.01.003
  2. Harada T, Nakamura F, Ikeda Y, et al. Successful catheter intervention for acute coronary syndrome in a patient with antiphospholipid syndrome. Jpn Heart J 2001;42:627-31. https://doi.org/10.1536/jhj.42.627
  3. Wilson WA, Gharavi, AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11. https://doi.org/10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F
  4. Asherson RA, Cervera R. Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist. Circulation 1991;84:920-3. https://doi.org/10.1161/01.CIR.84.2.920
  5. Cervera R. Coronary and valvular syndromes and antiphospholipid antibodies. Thromb Res 2004;114:501-7. https://doi.org/10.1016/j.thromres.2004.06.026
  6. Petri M, Lakatta C, Magder L, Goldman D. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 1994;96:254-9. https://doi.org/10.1016/0002-9343(94)90151-1
  7. Takeuchi S, Obayashi T, Toyama J. Primary antiphospholipid syndrome with acute myocardial infarction recanalised by PTCA. Heart 1998;79:96-8. https://doi.org/10.1136/hrt.79.1.96
  8. Sakakibara N, Kawasuji M, Matsumoto Y, Takemura H, Watanabe Y. Coronary artery bypass grafting in a patient with antiphospholipid syndrome. Ann Thorac Surg 1996;61: 739-40. https://doi.org/10.1016/0003-4975(95)00778-4

Cited by

  1. Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review vol.48, pp.None, 2011, https://doi.org/10.1016/j.blre.2020.100788